Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1Phase 2 1

Status

Completed 12Recruiting 7Not yet recruiting 5Terminated 4Unknown 3Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 3Breast 2Other 1

Conditions

Endometrial Neoplasms 2Endometrial Hyperplasia 2Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1Carcinoma, Endometrioid 1Breast Neoplasms 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Megestrol Acetate × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07543536 2026-04-22

MEGA-TACT-BC3

Sun Yat-sen University

Phase 3 Not yet recruiting
132 enrolled
Breast

Breast Neoplasms

NCT07436793 2026-02-27

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

New Mexico Cancer Research Alliance

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Hyperplasia

NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
120 enrolled
Breast

Breast Cancer Patients Treated With T-DXd

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
10 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡